Youyang Yang, MD

Director of Quality and Safety, Medical-Surgical Intensive Care Unit; Associate in Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine
Instructor of Anaesthesia, Harvard Medical School
Youyang Yang, MD
Phone 617-355-7327
NPI 1013320977
Print Profile
Request an Appointment
Locations

Youyang Yang, MD

Director of Quality and Safety, Medical-Surgical Intensive Care Unit; Associate in Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine
Instructor of Anaesthesia, Harvard Medical School

Medical Services

Programs & Services
Critical Care Medicine
Languages
English
Education
Undergraduate School
Harvard University
Cambridge
MA
Medical School
University of Massachusetts Medical School
Worcester
MA
Internship
Pediatrics
Massachusetts General Hospital
Boston
MA
Residency
Pediatrics
Massachusetts General Hospital
Boston
MA
Residency
Chief Resident
Massachusetts General Hospital
Boston
MA
Fellowship
Critical Care Medicine
Boston Children's Hospital
Boston
MA
Fellowship
Chief Fellow
Boston Children's Hospital
Boston
MA
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Critical Care Medicine)

Publications

Using Implementation Science to Assess Barriers to Agreement on Sedation Goal Setting and Assessment. View Abstract
Failure Modes and Effects Analysis to Evaluate Discharge Delays of Postoperative Tonsillectomy Patients From the Medical-Surgical PICU. View Abstract
Comparing the Quality of Domain-Specific Versus General Language Models for Artificial Intelligence-Generated Differential Diagnoses in PICU Patients. View Abstract
Medication Errors: Detection Methodology Matters. View Abstract
Implementation Science in Pediatric Critical Care - Sedation and Analgesia Practices as a Case Study. View Abstract
Implementation of an Analgesia-Sedation Protocol Is Associated With Reduction in Midazolam Usage in the PICU. View Abstract
"Closing the chasm" - guidelines bridge the gap from evidence to implementation. View Abstract
AML presenting with a preleukemic episode and acquired heterochromia in a child with macrosomia. View Abstract
A Case of Exertional Rhabdomyolysis: A Cheer for Standardizing Inpatient Management and Prevention. View Abstract
A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis. View Abstract
Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus. View Abstract
SALL4 is a key transcription regulator in normal human hematopoiesis. View Abstract
The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations. View Abstract
SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes. View Abstract
Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex. View Abstract
Locations